InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001628280-24-007970 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-02-29 2024-02-28 INSM Lewis William COB, CEO, Dir M - OptEx $12.58 +50.0K 50.5K +10,000% +$629.0K
DI 2024-02-29 2024-02-28 INSM Lewis William COB, CEO, Dir M - OptEx $0.00 +50.0K 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-28 M A 50,000 $12.58 50,500 I By ARTICLE 4 UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 — —
2 Derivative Stock Option (right to buy) 2024-02-28 M A 50,000 $0.00 0 I By ARTICLE 4 UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 $12.58 · — to 2024-06-02 50,000 Common Stock (F2) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.